Viracta Therapeutics Initiates Strategic Review and Halts NAVAL-1 Trial to Conserve Resources

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancer...

December 27, 2024 | Friday | News
Hoth Therapeutics Secures Exclusive Patent License from VA and Emory University to Tackle Obesity and Related Diseases

Hoth Therapeutics Enters Exclusive Patent License Agreement with VA and Emory University Hoth Also Expands Its' Intellectual Property to Further Its' Ma...

December 27, 2024 | Friday | News
AusperBio Therapeutics Secures $73M Series B Funding to Advance Targeted Therapies for Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

December 27, 2024 | Friday | News
Proton Intelligence Secures $6.95M Seed Funding to Advance Continuous Potassium Monitoring for Cardio-Kidney-Metabolic Care

Proton Intelligence Inc., developing the first-ever Continuous Potassium Monitoring (CKM™) platform,  announced the closing of its $6.95 milli...

December 26, 2024 | Thursday | News
Sanofi and SK bioscience Expand Collaboration to Develop Next-Generation Pneumococcal Vaccines for Global Impact

Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and...

December 24, 2024 | Tuesday | News
Catalent’s $16.5 Billion Acquisition by Novo Holdings Sets the Stage for Transforming Global Healthcare

Catalent, Inc. (“Catalent”), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S...

December 19, 2024 | Thursday | News
MSD and Hansoh Pharma Enter Exclusive Global License Agreement for Investigational GLP-1 Receptor Agonist HS-10535

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company,  announced that they ...

December 19, 2024 | Thursday | News
BD Resolves SEC Investigation with $175 Million Settlement Related to Alaris™ System Disclosures

BD (Becton, Dickinson and Company) , a leading global medical technology company,  issued the following statement: BD has reached an agreement with...

December 17, 2024 | Tuesday | News
Sandoz Resolves US Generic Drug Antitrust Class Action with $275 Million Settlement

Sandoz takes further steps to resolve legacy US generic drug antitrust class action litigation Sandoz US has entered into a settlement agreement with ...

December 17, 2024 | Tuesday | News
SK Biopharmaceuticals Forms Strategic Research Collaboration with ProEn Therapeutics to Advance Radiopharmaceutical Oncology Pipeline

SK Biopharmaceuticals, a biotech company focusing on the research, development and commercialization of treatments for disorders of the central nervous sys...

December 17, 2024 | Tuesday | News
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Partner to Advance Groundbreaking ALS Therapy

- Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to address the underlying patholo...

December 05, 2024 | Thursday | News
Philips and Mayo Clinic Partner to Enhance Cardiac MRI with AI to Improve Patient Experience and Operational Efficiency

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Thr...

December 04, 2024 | Wednesday | News
Gilead Sciences Partners with Tubulis to Develop Next-Generation Antibody-Drug Conjugate for Solid Tumors

Gilead Sciences, Inc. (Nasdaq: GILD) and Tubulis announced that they have entered into an exclusive option and license agreement to discover...

December 04, 2024 | Wednesday | News
Orikine Bio Secures €800k Funding to Accelerate Development of ORK-1 for Autoimmune Diseases

Orikine Bio, a pioneering biopharmaceutical company focused on the discovery, research and development of precision-engineered bi-specific cytokine therapi...

December 04, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close